Chapter III: Prohibited Acts and Penalties of the FD&C Act

The Federal Food, Drug, and Cosmetic Act (FD&C Act) is the cornerstone of food and drug law in the United States. Chapter III of the FD&C Act, titled "Prohibited Acts and Penalties," is one of its most critical sections. This chapter establishes what actions are illegal under federal law concerning food, drugs, devices, cosmetics, and tobacco products, and it outlines the consequences for violating these provisions.

Understanding Chapter III is essential for businesses, legal professionals, and consumers who want to ensure compliance with FDA regulations and avoid severe penalties.

What is Chapter III of the FD&C Act?

Chapter III of the FD&C Act, often referred to by its statutory citation as Section 301 (21 U.S.C. § 331), details a comprehensive list of prohibited acts related to the manufacture, distribution, and sale of food, drugs, devices, cosmetics, and tobacco products in the United States. This chapter forms the legal basis for most FDA enforcement actions and is central to the agency’s regulatory authority.

Section 301: The Heart of Prohibited Acts

Section 301 (21 U.S.C. § 331) is the primary section within Chapter III and enumerates the specific acts that are unlawful under the FD&C Act. These prohibited acts cover a wide range of activities, from introducing adulterated or misbranded products into interstate commerce to counterfeiting and falsifying records.

Key Prohibited Acts Include:

• Introduction or Delivery for Introduction into Interstate Commerce It is illegal to introduce or deliver for introduction into interstate commerce any food, drug, device, tobacco product, or cosmetic that is adulterated or misbranded.

  
  

• Adulteration or Misbranding in Interstate Commerce The act prohibits the adulteration or misbranding of any regulated product in interstate commerce.

  
  

• Receipt and Delivery of Adulterated or Misbranded Products Receiving in interstate commerce any adulterated or misbranded product and delivering or offering to deliver such products is prohibited.

  
  

• Refusal to Permit Access or Inspection Refusing to permit access to or copying of required records, or refusing to permit authorized inspections, is a violation.

  
  

• Counterfeiting and Fraudulent Activities Forging, counterfeiting, or falsely representing marks, labels, or identification devices, as well as manufacturing or selling counterfeit drugs or devices, are strictly forbidden.

  
  

• Failure to Register or Report Failing to register establishments, submit required reports, or provide necessary information as mandated by the FD&C Act constitutes a prohibited act.

  
  

• Import and Export Violations Importing or offering for import any regulated product in violation of the Act, especially by debarred individuals or companies, is illegal.

  
  

• Other Specific Prohibitions The Act also covers a range of other specific violations, such as falsifying declarations of conformity, failing to conduct post-approval studies, and more.

  
  

Section 302: Injunction Proceedings

Section 302 (21 U.S.C. § 332) empowers the federal government to seek injunctions against individuals or companies violating the FD&C Act. This means that the FDA, often working with the Department of Justice (DOJ), can ask a federal court to order violators to stop illegal activities. Injunctions are a powerful enforcement tool, especially in cases where public health is at risk.

Section 303: Penalties for Violations

Section 303 (21 U.S.C. § 333) outlines the penalties for violating the prohibited acts described in Section 301. Penalties can be civil or criminal, depending on the nature and severity of the violation.

Civil Penalties

• Civil penalties typically involve monetary fines and are used for less severe or unintentional violations.

• The maximum penalty can range from approximately $1,000 to over $1 million per violation, depending on the specific offense and whether it is a repeat violation.

• Civil penalties may also include debarment from certain activities, product seizures, and mandatory recalls.

Criminal Penalties

• Criminal penalties apply to more serious, intentional, or repeated violations.

• A person convicted of a criminal violation may face imprisonment for up to one year and/or a fine of up to $1,000 for a first offense.

• For subsequent offenses or violations involving fraud, gross negligence, or intent to defraud or mislead, penalties can increase to multiple years of imprisonment and fines up to $250,000 or more.

• Notably, criminal prosecution under the FD&C Act does not always require proof of intent or a "guilty mind" (mens rea). This means even unintentional violations can result in criminal liability.

Examples of Prohibited Acts Under Chapter III

To better understand the scope of Chapter III, here are some practical examples of prohibited acts:

• Selling Adulterated Food: A food manufacturer adds an unapproved chemical preservative to a product and ships it across state lines. This is both adulteration and a violation of interstate commerce provisions.

• Misbranding a Drug: A pharmaceutical company labels a drug with false or misleading information regarding its ingredients or intended use. Selling or distributing this drug is a prohibited act.

• Counterfeit Medical Devices: An importer brings in medical devices with forged FDA approval labels. This is a violation involving counterfeit devices and fraudulent labeling.

• Refusing FDA Inspection: A company refuses to allow FDA inspectors to access its manufacturing facility or records. This is a prohibited act and can result in injunctions or penalties.

• Failure to Report Adverse Events: A drug manufacturer fails to report required post-market safety data to the FDA. This omission is a violation of reporting requirements.

Enforcement of Chapter III: How the FDA Acts

The FDA has a wide range of enforcement tools at its disposal to address violations of Chapter III. Enforcement actions can be administrative, civil, or criminal, depending on the circumstances.

Administrative Actions

• Warning Letters: The FDA may issue warning letters to companies or individuals suspected of violations, giving them an opportunity to correct the issue before further action is taken.

• Import Alerts and Detentions: Products found to be in violation may be detained at the border or subject to import alerts, preventing their entry into the U.S. market.

• Recalls: The FDA can mandate or request recalls of products that pose a risk to public health due to violations of the FD&C Act.

Civil Actions

• Injunctions: As discussed, the FDA can seek court orders to stop ongoing violations.

• Seizures: The government can seize products that are adulterated, misbranded, or otherwise in violation of the law.

• Monetary Penalties: Fines can be imposed for each violation, with higher amounts for repeat or egregious offenses.

Criminal Actions

• Prosecution: For serious or repeated violations, the FDA may refer cases to the DOJ for criminal prosecution. Convictions can result in imprisonment, substantial fines, and other penalties.

Why Compliance Matters: The Impact of Chapter III

Compliance with Chapter III of the FD&C Act is not optional for companies operating in the food, drug, device, cosmetic, or tobacco industries. The consequences of violating these provisions can be severe, including:

• Financial Losses: Fines, product seizures, recalls, and legal costs can be financially devastating for businesses.

• Reputational Damage: Public knowledge of violations can harm a company’s reputation and consumer trust.

• Loss of Market Access: Products detained or refused entry at the border can disrupt supply chains and market access.

• Criminal Liability: Company executives and employees can face personal criminal liability for violations.

Common Defenses and Legal Considerations

While the FD&C Act is strict, there are some defenses and legal considerations for those accused of violations:

• Good Faith and Lack of Knowledge: In some cases, defendants may argue they acted in good faith or were unaware of the violation. However, this is not always a defense, especially for strict liability offenses.

• Corrective Actions: Promptly correcting violations after receiving an FDA warning may mitigate penalties or prevent escalation to criminal charges.

• Challenging FDA Actions: Companies may challenge FDA enforcement actions in court, though the agency’s authority is broad.

The Importance of Understanding Chapter III

Chapter III of the FD&C Act, covering prohibited acts and penalties, is foundational to the FDA’s ability to protect public health and ensure the safety and integrity of food, drugs, devices, cosmetics, and tobacco products in the United States. The chapter’s broad scope means that nearly every action involving these products-from manufacturing and labeling to importation and distribution-is subject to strict federal oversight. Violations can lead to significant civil and criminal penalties, making compliance a top priority for regulated industries.

For anyone involved in the production, distribution, or sale of FDA-regulated products, a thorough understanding of Chapter III is essential. Staying informed and proactive about compliance can help avoid costly enforcement actions and protect both consumers and businesses.

Summary Table: Key Prohibited Acts and Penalties Under Chapter III

Prohibited Act	Example Violation	Possible Penalty
Adulteration or Misbranding	Adding unapproved substances to food	Civil fines, product seizure
Counterfeiting	Selling fake drugs or devices	Criminal prosecution, prison
Refusal of Inspection	Denying FDA access to facility	Injunction, civil/criminal fines
Failure to Register or Report	Not submitting required FDA reports	Civil penalties, debarment
Import/Export Violations	Importing banned products	Detention, fines, criminal case

For more information on Chapter III: Prohibited Acts and Penalties of the FD&C Act, consult the official U.S. Code or FDA regulatory resources for the most current legal requirements and guidance.

---

Howard Law is a business, regulatory and M&A law firm in the greater Charlotte, North Carolina area, with additional services in M&A advisory and business brokerage. Howard Law is a law firm based in the greater Charlotte, North Carolina area focused on business law, corporate law, regulatory law, mergers & acquisitions, M&A advisor and business brokerage. Handling all business matters from incorporation to acquisition as well as a comprehensive understanding in assisting through mergers and acquisition. The choice of a lawyer is an important decision and should not be based solely on advertisements. The information on this website is for general and informational purposes only and should not be interpreted to indicate a certain result will occur in your specific legal situation. Information on this website is not legal advice and does not create an attorney-client relationship. You should consult an attorney for advice regarding your individual situation. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.